NASDAQ:WINT

Windtree Therapeutics Insider Trades

$2.15
+0.01 (+0.47 %)
(As of 04/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.01
Now: $2.15
$2.15
50-Day Range
$2.14
MA: $3.19
$5.10
52-Week Range
$2.01
Now: $2.15
$10.06
Volume641,399 shs
Average Volume332,237 shs
Market Capitalization$56.45 million
P/E RatioN/A
Dividend YieldN/A
Beta0.25

Insider Trades

Windtree Therapeutics (NASDAQ:WINT) Insider Buying and Selling Activity

Insider Ownership Percentage: 14.91%
Insider Buying (Last 12 Months): $387,127.32
Insider Selling (Last 12 Months): $0.00

Insider Buying and Selling by Quarter


Windtree Therapeutics (NASDAQ WINT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/16/2021John P HamillCFOBuy1,000$2.07$2,070.00  
4/7/2021Eric CurtisCOOBuy791$2.52$1,993.321,291  
4/5/2021Craig FraserCEOBuy1,000$2.58$2,580.0027,798  
3/31/2021Craig FraserCEOBuy500$2.32$1,160.0026,298  
3/31/2021James HuangDirectorBuy150,000$2.36$354,000.00171,000  
3/25/2021Steven SimonsonSVPBuy1,500$3.25$4,875.0012,302  
10/28/2020Craig FraserCEOBuy250$6.56$1,640.0024,298  
10/23/2020James HuangDirectorBuy1,000$6.67$6,670.0021,000  
10/9/2020Craig FraserCEOBuy250$5.83$1,457.5024,048  
10/8/2020Eric CurtisCOOBuy500$5.27$2,635.00500  
10/7/2020Craig FraserCEOBuy250$5.17$1,292.5023,798  
10/7/2020John P HamillCFOBuy1,000$5.27$5,270.001,000  
6/3/2020James HuangDirectorBuy200$7.42$1,484.008,000  
1/17/2020James HuangDirectorBuy2,058$4.45$9,158.10
12/30/2019James HuangDirectorBuy5,000$4.25$21,250.00
12/21/2018Lph Ii Investments LtdMajor ShareholderBuy1,810,938$3.31$5,994,204.78  
4/4/2018Pharmaceutical Holdings Lee'sMajor ShareholderBuy541,667$4.80$2,600,001.60  
10/28/2016Craig FraserInsiderBuy7,500$2.05$15,375.007,500  
2/19/2013John R LeoneDirectorBuy3,000$2.88$8,640.00  
(Data available from 1/1/2013 forward)
This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.